The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

Experts today sounded an alarm over the death toll as millions more are in line to get the jabs to curb the nation's bulging waistline.

HOUSTON — The dual GLP-1/GIP receptor agonist tirzepatide showed significantly greater efficacy than the GLP-1 dulaglutide in the treatment of major kidney outcomes in patients with type 2 diabetes ...

A prespecified analysis of the SURPASS CVOT trial examining patients with high-risk CKD suggested tirzepatide reduces the risk of major kidney events, particularly eGFR decline and albuminuria, ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...

KNOXVILLE, Tenn. — UPDATE WEDNESDAY: A Knox County chancellor said Wednesday he'll review - behind closed doors - information sought by a death row inmate about the state's lethal injection drug. By ...

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals for the treatment of patients with macular edema following retinal vein ...

Pluribus Episode 4 ends with Carol injecting truth serum into Zosia to force answers about reversing the Joining. What ...

MONDAY, Nov. 24, 2025 (HealthDay News) — Researchers say a woman struggling with obesity who couldn’t resist eating fatty ...